Dr. Guy has devoted his career to solving problems encountered in the development of therapies for treating human diseases. Dr. Guy’s degrees in biochemistry, immunology, and pharmacology and willingness to expand his horizons have provided a strong basis for achieving these aspirations.

During his career, Dr. Guy has been engaged in various critical facets of pharmaceutical development in order to maximize his capabilities for leading the research and development of pharmaceutical, nanopharmaceutical, and biopharmaceutical products. Dr. Guy’s diversified background and experience enable him to understand medical problems and approach and solve the variety of obstacles encountered in pharmaceutical development.   

Dr. Guy has led development of these therapeutic products for over 27 years during which he has been an inventor, director of project management, regulatory affairs, quality systems, Intellectual property, auditing, or pharmaceutical development. 

Dr. Guy  contributed to the commercial and clinical advancement of >15 products including Alrex, Lotemax, Zylet, BioLon, Biotropin, Bio-Hep-B, and Krystexxa.